Ligand Pharmaceuticals (LGND) Return on Capital Employed Growth (3y) (2014 - 2026)
Ligand Pharmaceuticals (LGND) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4,893.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2,416.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -494.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -649.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,782.00 |
| 10 | Ligand Pharmaceuticals | 6.05 Bn | 5.27 Bn | 48.45 Mn | 409.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 409.00 |
| Dec 31, 2025 | 239.00 |
| Sep 30, 2025 | -507.00 |
| Jun 30, 2025 | -1,093.00 |
| Mar 31, 2025 | -1,589.00 |
| Dec 31, 2024 | -1,083.00 |
| Sep 30, 2024 | -909.00 |
| Jun 30, 2024 | -818.00 |
| Mar 31, 2024 | -303.00 |
| Dec 31, 2023 | -154.00 |
| Sep 30, 2023 | -101.00 |
| Jun 30, 2023 | 97.00 |
| Mar 31, 2023 | 338.00 |
| Dec 31, 2022 | -5,328.00 |
| Sep 30, 2022 | -4,533.00 |
| Jun 30, 2022 | -4,330.00 |
| Mar 31, 2022 | -5,932.00 |
| Dec 31, 2021 | -188.00 |
| Sep 30, 2021 | -612.00 |
| Jun 30, 2021 | -1,627.00 |